(5R,5aR,8aR,9S)-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one; Lignan P; (5R,5aR,8aR,9S)-9-(?-D-Glucopyranosyloxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-uro[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one; ?-D-4'-Demethylepipodophyllotoxin Glucopyranoside; 4-Demethylepipodophyllotoxin 7'-O-?-D-glucopyranoside; 4'-Demethylepipodophyllotoxin glucoside; Pptoxin II
Etoposide EP Impurity D is a fully characterized chemical compound used as a reference standard of API Etoposide. The standard offered is compliant with regulatory guidelines. Etoposide EP Impurity D is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 23363-35-1
Related products
Sodium Salt cis-Etoposide Hydroxy Acid
M.F.
M.W. 605.58 22.99
CAT# AR-E02173
CAS# 109010-92-6 (free acid)
